Carboxylesterase-expressing allogeneic neural stem cells

· City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carboxylesterase-expressing allogeneic neural stem cells, covering 2024-04-29 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]

See pricing